drugset / Trial / NCT00168051

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

NCT00168051

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to compare the pharmacokinetic parameters of ReFacto and Advate, using the chromogenetic substrate assay to measure plasma Factor VIII activity in plasma.

Timeline

Start
2005-04
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Advante Protein / enzyme biologic
Subject Moroctocog alfa Protein / enzyme biologic

Indications